Robert E. Miller

发表

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

C. Rauch, T. Griffith, H. Walczak, 1999, Nature Medicine.

Flt3 ligand induces tumor regression and antitumor immune responses in vivo

Robert E. Miller, J. Schuh, D. Lynch, 1997, Nature Medicine.

MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer

J. Blankenship, J. Gross, C. Mcmahan, 2016, Molecular Cancer Therapeutics.

Large Molecule Therapeutics MOR 209 / ES 414 , a Novel Bispeci fi c Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer

J. Blankenship, J. Gross, C. Mcmahan, 2016 .

Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection.

D. Branstetter, W. Dougall, Robert E. Miller, 2007, Journal of immunology.

Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells.

M. Roudier, K. Stocking, Robert E. Miller, 2009, Comparative medicine.

of Antitumor Immunity In Vivo Induction of Dendritic Cells and Generation Kinase 3 Ligand and CD40 Ligand in the Synergistic Action of fms-Like Tyrosine

Whitmore, W. Fanslow, Robert E. Miller, 1999 .

Mice lacking flt 3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells , dendritic cells , and natural killer cells

B. Pulendran, J. Peschon, K. Stocking, 2022 .

4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner

N. Boiani, Robert E. Miller, B. Gliniak, 2002, The Journal of Immunology.

In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti‐tumor cytotoxic T lymphocytes

Robert E. Miller, D. Lynch, A. Namen, 1991, European journal of immunology.

CD8 T Cells in a CD40-Dependent Manner Immune Responses by Direct Activation of Promotes the Generation of Tumor-Specific 4-1BB-Specific Monoclonal Antibody

Robert E. Miller, B. Gliniak, Jon C Jones, 2002 .

gld/gld mice are unable to express a functional ligand for Fas

F. Ramsdell, Robert E. Miller, D. Lynch, 1994, European journal of immunology.

Induction of apoptosis in mature T cells by tumour necrosis factor

M. Lenardo, J. Peschon, Robert E. Miller, 1995, Nature.

Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor‐bearing mice

Robert E. Miller, D. Lynch, R. Miller, 1991, European journal of immunology.

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

D. Branstetter, W. Dougall, J. Pinkas, 2010, Nature.

RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

J. Canon, M. Roudier, W. Dougall, 2008, Molecular Cancer Therapeutics.

RANK expression on breast cancer cells promotes skeletal metastasis

W. Dougall, Robert E. Miller, Jon C Jones, 2013, Clinical & Experimental Metastasis.

Abstract 1786: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity, induces potent T-cell activation, proliferation and cytotoxicity with limited cytokine release

J. Gross, Robert E. Miller, D. Bienvenue, 2018, Immunology.

Abstract 597: Bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecules for redirected T-cell cytotoxicity in hematological malignancies

J. Blankenship, P. Pavlík, J. Gross, 2017 .

RANK expression on breast cancer cells promotes skeletal metastasis

W. Dougall, Robert E. Miller, Jon C Jones, 2014, Clinical & Experimental Metastasis.

Flt3 ligand: A dendritic cell (DC)-stimulating cytokine that induces tumor regression and anti-tumor immune responses in vivo

Robert E. Miller, J. Schuh, D. Lynch, 1997 .

Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis.

A. Coxon, J. Canon, R. Bryant, 2010, Bone.

RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

W. Dougall, Jian Zhang, E. Keller, 2008, The Prostate.

Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand.

D. Kyle, C. Wongsrichanalai, Robert E. Miller, 2005, The American journal of tropical medicine and hygiene.

RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases

W. Dougall, Robert E. Miller, Jon C Jones, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non – Small-Cell Lung Cancer Bone Metastases

W. Dougall, Robert E. Miller, Jon C Jones, 2014 .

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis

M. Roudier, W. Dougall, Robert E. Miller, 2010, Cancer biology & therapy.

RANKLActsDirectlyonRANK-Expressing Prostate TumorCells andMediatesMigration andExpression of TumorMetastasisGenes

W. Dougall, Jian Zhang, E. Keller, 2007 .

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.

M R Alderson, C A Smith, K. Hunter, 1994, Immunity.

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

B. Pulendran, J. Peschon, K. Stocking, 2000, Blood.

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.

F. Ramsdell, Robert E. Miller, D. Lynch, 1994, International immunology.

Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo

Robert E. Miller, D. Lynch, R. Miller, 1994, The Journal of experimental medicine.

Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo

Robert E. Miller, D. Lynch, 1994, The Journal of experimental medicine.

Protective Effects of Recombinant Human Interleukin-la in Doxorubicin-treated Normal and Tumor-bearing Mice

Douglas, Robert E. Miller, D. Lynch, 2006 .